Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially opening the door to new treatments ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

With about 190,000 people in the UK living with the disease and 10,000 diagnosed annually, the early treatment method could ...

Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...

Your gut harbors trillions of microbes which live in precarious harmony with your immune system. When that harmony is upset, ...

UC San Diego researchers have resolved a decades-long debate about the role of the first Crohn’s disease gene linked to an increased risk of developing the autoimmune condition. The human digestive ...

UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be ...

How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a cytokine ...

Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...